Our Newsroom
This is the place to get the latest exciting news about Route 92 medical.
Route 92 Medical Appoints Medtech Industry Leader Pat Mackin to its Board of Directors
San Mateo, CA / West Jordan, UT, November 6, 2025 — Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced the election of Pat Mackin to its Board of Directors. His appointment brings deep commercial, operational, business development, and executive leadership experience in […]
View More
Route 92 Medical® Announces Publication of Initial SUMMIT NZ Clinical Trial Results Demonstrating 80% First Pass Effect with the 088 Monopoint® Operating Platform
View More
Route 92 Medical® Announces Receipt of 40th Patent for its Monopoint® Operating Platform Designed for Neurovascular Intervention
View More
Route 92 Medical® Announces First Patient Enrollment in the SUMMIT MAX Pivotal Clinical Trial for the Monopoint® Reperfusion System
View More